AEPC 2026

(Annual Meeting of the Association for European Paediatric and Congenital Cardiology)

May 13-16, 2026

AEPC 2026 marked TaeWoong Medical's first participation in one of Europe's largest congresses dedicated to adult and pediatric interventional cardiology. Following the recent CE approval of PULSTA, the congress provided an important opportunity to introduce the device to interventional cardiologists and healthcare professionals from across Europe. As a leading scientific meeting in the field, AEPC offered a valuable platform to increase awareness of PULSTA and engage with key stakeholders in the European market.

TaeWoong Medical showcased PULSTA at its exhibition booth featuring a realistic 3D-printed valve model, drawing attention from attendees throughout the event. The congress also enabled productive discussions with physicians and industry partners, while providing hands-on PULSTA loading and deployment training for the Italian distributor team. Participation in AEPC 2026 reinforced TaeWoong Medical's commitment to expanding access to innovative pulmonary valve solutions and strengthening its presence in Europe following CE approval.